201 related articles for article (PubMed ID: 36517908)
1. Long-term survivors demonstrate superior quality of life after haploidentical stem cell transplantation to matched sibling donor transplantation.
Zhang X; Wang J; Liu Y; Liu J; Wang B; Zhang Q; Guan W; Zhang H; Xu L; Liu G; Zhang P; He Y; Feng S; Han M; Li C; Jiang E; Xie W
J Transl Med; 2022 Dec; 20(1):596. PubMed ID: 36517908
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Recipient Health-Related Quality of Life and Donor-Recipient Relationship following Sibling Pediatric Hematopoietic Stem Cell Transplantation.
Zając-Spychała O; Pieczonka A; Barańska M; Wachowiak J
Biol Blood Marrow Transplant; 2020 Feb; 26(2):401-406. PubMed ID: 31622770
[TBL] [Abstract][Full Text] [Related]
3. Comparison of efficacies of haploidentical transplantation and matched sibling donor transplantation in treating T-cell lymphoblastic lymphoma.
Wei R; Fang J; Shi W; Lu X; Wu Y; Jiang S; Zhang A; Liao S; Qin C; Cui G; Xia L
Cancer Med; 2023 May; 12(9):10499-10511. PubMed ID: 36992548
[TBL] [Abstract][Full Text] [Related]
4. Comparable outcomes among unmanipulated haploidentical, matched unrelated, and matched sibling donors in BU-based myeloablative hematopoietic stem cell transplantation for intermediate and adverse risk acute myeloid leukemia in complete remission: a single-center study.
Lu Y; Zhao YL; Zhang JP; Xiong M; Cao XY; Liu DY; Sun RJ; Wei ZJ; Zhou JR; Lu DP
Ann Hematol; 2021 Jun; 100(6):1579-1591. PubMed ID: 33236196
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Hematopoietic Stem Cell Transplantation Outcomes Using Matched Sibling Donors, Haploidentical Donors, and Immunosuppressive Therapy for Patients With Acquired Aplastic Anemia.
Zhang Y; Huo J; Liu L; Shen Y; Chen J; Zhang T; Chen X; Pang A; Yang D; Zhang R; Ma Q; Zhai W; He Y; Wei J; Jiang E; Han M; Zheng Y; Feng S
Front Immunol; 2022; 13():837335. PubMed ID: 35178053
[TBL] [Abstract][Full Text] [Related]
6. Outcome of Haploidentical Peripheral Blood Allografts Using Post-Transplantation Cyclophosphamide Compared to Matched Sibling and Unrelated Donor Bone Marrow Allografts in Pediatric Patients with Hematologic Malignancies: A Single-Center Analysis.
Srinivasan A; Raffa E; Wall DA; Schechter T; Ali M; Chopra Y; Kung R; Chiang KY; Krueger J
Transplant Cell Ther; 2022 Mar; 28(3):158.e1-158.e9. PubMed ID: 34838785
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of clinical features of hemorrhagic cystitis after haploidentical and matched sibling donor allogeneic hematopoietic stem cell transplantation].
Zheng FM; Fu HX; Han TT; Wang FR; Wang JZ; Chen Y; Yan CH; Zhang YY; Han W; Chen YY; Chen H; Wang Y; Zhang XH; Liu KY; Huang XJ; Xu LP
Zhonghua Xue Ye Xue Za Zhi; 2017 Aug; 38(8):656-661. PubMed ID: 28954342
[No Abstract] [Full Text] [Related]
8. Early-phase differences in health-related quality of life, psychological status, and physical function between human leucocyte antigen-haploidentical and other allogeneic haematopoietic stem cell transplantation recipients.
Morishita S; Kaida K; Yamauchi S; Wakasugi T; Ikegame K; Kodama N; Ogawa H; Domen K
Eur J Oncol Nurs; 2015 Oct; 19(5):443-50. PubMed ID: 25911269
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of haploidentical hematopoietic stem cell transplantation and matched-sibling donor transplantation for the treatment of paroxysmal nocturnal hemoglobinuria].
Liu LM; Zhou HF; Wang QY; Qiu HY; Tang XW; Han Y; Fu CC; Jin ZM; Chen SN; Sun AN; Miao M; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2019 Apr; 40(4):306-311. PubMed ID: 31104442
[No Abstract] [Full Text] [Related]
10. Patients receiving HLA-haploidentical/partially matched related allo-HSCT can achieve desirable health-related QoL that is comparable to that of patients receiving HLA-identical sibling allo-HSCT.
Mo XD; Xu LP; Liu DH; Chen YH; Han W; Zhang XH; Chen H; Wang Y; Wang JZ; Liu KY; Huang XJ
Bone Marrow Transplant; 2012 Sep; 47(9):1201-5. PubMed ID: 22231459
[TBL] [Abstract][Full Text] [Related]
11. Haploidentical related donor vs matched sibling donor allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome aged over 50 years: A single-center retrospective study.
Huang J; Huang F; Fan Z; Xu N; Xuan L; Liu H; Shi P; Jiang L; Zhang Y; Sun J; Liu Q
Cancer Med; 2020 Sep; 9(17):6244-6255. PubMed ID: 32686915
[TBL] [Abstract][Full Text] [Related]
12. [Outcome of allogeneic hematopoietic stem cell transplantation from HLA-matched sibling donor for 41 cases of severe aplastic anemia].
Chen X; Wei JL; Huang Y; He Y; Yang DL; Jiang EL; Ma QL; Zhou LK; Lin XT; Shen YY; Feng SZ; Han MZ
Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):610-4. PubMed ID: 23134851
[TBL] [Abstract][Full Text] [Related]
13. Comparison of hematopoietic stem cell transplantation and immunosuppressive therapy as the first-line treatment option for patients with severe hepatitis-associated aplastic anemia.
Zhang X; Yang W; Yang D; Wei J; Zhang P; Feng S; Jiang E; Zhang L; He Y; Zhang F; Han M
Front Immunol; 2023; 14():1146997. PubMed ID: 37006284
[TBL] [Abstract][Full Text] [Related]
14. Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of philadelphia chromosome-positive acute lymphoblastic leukemia.
Chen H; Liu KY; Xu LP; Chen YH; Han W; Zhang XH; Wang Y; Qin YZ; Liu YR; Huang XJ
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1110-6. PubMed ID: 25698612
[TBL] [Abstract][Full Text] [Related]
15. Risk factors and associations with clinical outcomes of cytomegalovirus reactivation after haploidentical versus matched-sibling unmanipulated PBSCT in patients with hematologic malignancies.
Gao XN; Lin J; Wang LJ; Li F; Li HH; Wang SH; Huang WR; Gao CJ; Yu L; Liu DH
Ann Hematol; 2020 Aug; 99(8):1883-1893. PubMed ID: 32572523
[TBL] [Abstract][Full Text] [Related]
16. Unmanipulated haplo-identical donor transplantation compared with identical sibling donor had better anti-leukemia effect for refractory/relapsed acute myeloid leukemia not in remission status.
Lu Y; Zhao YL; Zhang JP; Xiong M; Cao XY; Liu DY; Sun RJ; Wei ZJ; Zhou JR; Lu DP
Ann Hematol; 2020 Dec; 99(12):2911-2925. PubMed ID: 33000361
[TBL] [Abstract][Full Text] [Related]
17. Comparable long-term outcomes between upfront haploidentical and identical sibling donor transplant in aplastic anemia: a national registry-based study.
Xu ZL; Xu LP; Wu DP; Wang SQ; Zhang X; Xi R; Gao SJ; Xia LH; Yang JM; Jiang M; Wang X; Liu QF; Chen J; Zhou M; Huang XJ
Haematologica; 2022 Dec; 107(12):2918-2927. PubMed ID: 35615930
[TBL] [Abstract][Full Text] [Related]
18. Comparable Outcomes in Acquired Severe Aplastic Anemia Patients With Haploidentical Donor or Matched Related Donor Transplantation: A Retrospective Single-Center Experience.
Wang Q; Ren H; Liang Z; Liu W; Yin Y; Wang Q; Wang Q; Sun Y; Xu W; Qiu Z; Ou J; Han N; Wang J; Dong Y; Li Y
Front Med (Lausanne); 2021; 8():807527. PubMed ID: 35141252
[TBL] [Abstract][Full Text] [Related]
19. Haploidentical allogeneic hematopoietic stem cell transplantation increases the risk of cytomegalovirus infection in adult patients with acute leukemia.
Lin CH; Su YJ; Hsu CY; Wang PN; Teng CJ
Transpl Infect Dis; 2019 Aug; 21(4):e13096. PubMed ID: 31004545
[TBL] [Abstract][Full Text] [Related]
20. [HLA-10/10 matched unrelated donor versus sibling donor hematopoietic stem cell transplantation for adult acute myeloid leukemia].
Yao JF; Zhang GX; Shen YY; Zhang RL; He Y; Wei JL; Jiang EL; Yang DL; Feng SZ; Han MZ
Zhonghua Xue Ye Xue Za Zhi; 2019 Jun; 40(6):460-466. PubMed ID: 31340617
[No Abstract] [Full Text] [Related]
[Next] [New Search]
